ChemAxon, a Pistoia Alliance member, has today announced a deal that will see its CSCS-based solution, Compliance Checker, deployed at …
Controlled Substance Compliance Services (CSCS), a project managed by the Pistoia Alliance, which helps companies check the legal requirements around using controlled substances in pharmaceutical research, is set to expand to China.
An article describing CSCS, its Expert Community, and recent work to expand the project's scope to include Chinese legislation was published in Scrip Regulatory Affairs on January 9th.
Newly published research in Drug Discovery Today highlights the value of pharma companies collaborating to fix shared challenges.
A case study on CSCS from Novartis.
Our Controlled Substances Compliance Services (CSCS) project has made it significantly easier for life science companies to comply with controlled substance legislation by establishing an expert community to interpret the often-ambiguous rules.
The proposal for the CSCS Expert Community originated from the Pistoia Alliance CSCS Project, which ran from November 2012 – April 2014. The CSCS Project completed successfully with the delivery of two commercially available Controlled Substance Compliance Services by ChemAxon/Patcore and Scitegrity.
Controlled Substance legislation is complex and ever changing. As such, it requires on-going and detailed interpretation to identify those compounds that are within scope of regional and international laws.